Immunoglobulin Market - Global Industry Analysis

Name: Immunoglobulin Market by Mode of Delivery (Subcutaneous and Intravenous), by Application (Hypogammaglobulinemia, Immunodeficiency Disease, Multifocal Motor Neuropathy, Guillain-Barre Syndrome, Myasthenia Gravis, Chronic Inflammatory Demyelinating Polyneuropathy, Idiopathic Thrombocytopenic Purpura, Specific Antibody Deficiency, Inflammatory Myopathies, and Others), and by Product Type (IgA, IgD, IgG, IgE, and IgM): Global Industry Perspective, Comprehensive Analysis, and Forecast, 2017—2024
Brand: Zion Market Research
SKU: ZMR-3763
Price: 4199.00 USD
Availability: InStock
Rating: 4.4 (89 reviews)

Immunoglobulin Market by Mode of Delivery (Subcutaneous and Intravenous), by Application (Hypogammaglobulinemia, Immunodeficiency Disease, Multifocal Motor Neuropathy, Guillain-Barre Syndrome, Myasthenia Gravis, Chronic Inflammatory Demyelinating Polyneuropathy, Idiopathic Thrombocytopenic Purpura, Specific Antibody Deficiency, Inflammatory Myopathies, and Others), and by Product Type (IgA, IgD, IgG, IgE, and IgM): Global Industry Perspective, Comprehensive Analysis, and Forecast, 2017—2024

Published Date: 25-Jan-2019 Category: Healthcare Report Format : PDF Pages: 110 Report Code: ZMR-3763 Status : Published

Global immunoglobulin market expected to generate around USD 16.6 billion by 2024, at a CAGR of around 7.6% between 2018 and 2024. Increasing geriatric population worldwide, steep rise in the cases of neurological disorders, and rising hemophilic patient numbers are likely to drive the global immunoglobulin market in the upcoming years.

Request For Customization Request Free Brochure Request Free Sample Buy Now

Description

The report covers a forecast and an analysis of the immunoglobulin market on a global and regional level. The study provides historical data for 2015, 2016, and 2017 along with a forecast from 2018 to 2024 based on revenue (USD Billion). The study includes drivers and restraints for the immunoglobulin market along with the impact they have on the demand over the forecast period. Additionally, the report includes the study of opportunities available in the immunoglobulin market on a global and regional level.

In order to give the users of this report a comprehensive view of the immunoglobulin market, we have included a competitive landscape and an analysis of Porter’s Five Forces model for the market. The study encompasses a market attractiveness analysis, wherein all the segments are benchmarked based on their market size, growth rate, and general attractiveness.

Global Immunoglobulin Market

The report provides company market share analysis to give a broader overview of the key market players. In addition, the report also covers key strategic developments of the market including acquisitions & mergers, new product launch, agreements, partnerships, collaborations & joint ventures, research & development, and regional expansion of major participants involved in the immunoglobulin market on a global and regional basis.

The study provides a decisive view of the immunoglobulin market by segmenting the market based on mode of delivery, application, product type, and region. By mode of delivery, the immunoglobulin market is segmented into subcutaneous and intravenous. Subcutaneous is further segmented into 16.5% concentration, 20% concentration, and others. Intravenous is further segmented into 5% concentration, 10% concentration, and others. The application segment includes Hypogammaglobulinemia, Immunodeficiency Disease, Multifocal Motor Neuropathy, Guillain-Barre Syndrome, Myasthenia Gravis, Chronic Inflammatory Demyelinating Polyneuropathy, Idiopathic Thrombocytopenic Purpura, Specific Antibody Deficiency, Inflammatory Myopathies, and others. By product type, this market includes IgA, IgD, IgG, IgE, and IgM.

The regional segmentation includes the current and forecast demand for North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa with its further classification into major countries including the U.S., Germany, France, UK, China, Japan, India, and Brazil.

Some market players of the global immunoglobulin market are ADMA Biologics, Inc., Shire plc, CSL Behring LLC, China Biologic Products, Inc., Grifols S.A., LFB Biomedicaments S.A., Kedrion S.p.A., Sanquin Plasma Products B.V., and Octapharma AG, among others.

This report segments the global immunoglobulin market into:

Global Immunoglobulin Market: By Mode of Delivery

Subcutaneous
- 16.5% Concentration
- 20% Concentration
- Others
Intravenous
- 5% Concentration
- 10% Concentration
- Others

Global Immunoglobulin Market: By Application

Hypogammaglobulinemia
Immunodeficiency Disease
Multifocal Motor Neuropathy
Guillain-Barre Syndrome
Myasthenia Gravis
Chronic Inflammatory Demyelinating Polyneuropathy
Idiopathic Thrombocytopenic Purpura
Specific Antibody Deficiency
Inflammatory Myopathies
Others

Global Immunoglobulin Market: By Product Type

Global Immunoglobulin Market: By Region

North America
- The U.S.
Europe
- UK
- France
- Germany
Asia Pacific
- China
- Japan
- India
Latin America
- Brazil
Middle East and Africa

Table Of Content

Chapter 1. Introduction
- 1.1. Report description and scope
- 1.2. Research scope
- 1.3. Research methodology
  - 1.3.1. Market research process
  - 1.3.2. Market research methodology
Chapter 2. Executive Summary
- 2.1. Global Immunoglobulin market, 2017-2024(USD Billion)
- 2.2. Global Immunoglobulin market: Snapshot
Chapter 3. Immunoglobulin Market - Industry Dynamics
- 3.1. Introduction
- 3.2. Market drivers
  - 3.2.1. Growing incidence of autoimmune diseases
  - 3.2.2. Steep rise in the cases of neurological disorders
- 3.3. Market Restraints
  - 3.3.1. Strict government guidelines with respect to immunoglobulin products
  - 3.3.2. High side effects risk due to immunoglobulin use
- 3.4. Opportunities
  - 3.4.1. Technological advancements in purification and production methods
  - 3.4.2. Efforts taken by government and non-government organizations to create awareness regarding autoimmune diseases
- 3.5. Porter's Five Forces analysis
  - 3.5.1. Bargaining power of suppliers
  - 3.5.2. Bargaining power of buyers
  - 3.5.3. The threat from new entrants
  - 3.5.4. The threat from new substitutes
  - 3.5.5. Degree of competition
- 3.6. Market attractiveness analysis
  - 3.6.1. Market attractiveness analysis, by Mode of Delivery
  - 3.6.2. Market attractiveness analysis, by Application
  - 3.6.3. Market attractiveness analysis, by Product Type
Chapter 4. Global Immunoglobulin Market - Competitive Landscape
- 4.1. Company Market Share Analysis
  - 4.1.1. Global Immunoglobulin market: company market share, 2017
- 4.2. Strategic Development
  - 4.2.1. Acquisitions & Mergers
  - 4.2.2. New Product Launch
  - 4.2.3. Agreements, Partnerships, Collaborations and Joint Ventures
  - 4.2.4. Research and Development, Regional Expansion
Chapter 5. Global Immunoglobulin Market - Mode of Delivery Analysis
- 5.1. Global Immunoglobulin market: Mode of Delivery overview
  - 5.1.1. Global Immunoglobulin market revenue share, by Mode of Delivery, 2017 and 2024
- 5.2. Subcutaneous
  - 5.2.1. Global Immunoglobulin market for Subcutaneous, 2017 - 2024(USD Billion)
- 5.3. Intravenous
  - 5.3.1. Global Immunoglobulin market for Intravenous, 2017 - 2024(USD Billion)
Chapter 6. Global Immunoglobulin Market - Application Analysis
- 6.1. Global Immunoglobulin market: Application overview
  - 6.1.1. Global Immunoglobulin market revenue share, by Application, 2017 and 2024
- 6.2. Hypogammaglobulinemia
  - 6.2.1. Global Immunoglobulin market for Hypogammaglobulinemia, 2017 - 2024 (USD Billion)
- 6.3. Immunodeficiency Disease
  - 6.3.1. Global Immunoglobulin market for Immunodeficiency Disease, 2017 - 2024 (USD Billion)
- 6.4. Multifocal Motor Neuropathy
  - 6.4.1. Global Immunoglobulin market for Multifocal Motor Neuropathy, 2017 - 2024 (USD Billion)
- 6.5. Guillain-Barre Syndrome
  - 6.5.1. Global Immunoglobulin market for Guillain-Barre Syndrome, 2017 - 2024 (USD Billion)
- 6.6. Myasthenia Gravis
  - 6.6.1. Global Immunoglobulin market for Myasthenia Gravis, 2017 - 2024 (USD Billion)
- 6.7. Chronic Inflammatory Demyelinating Polyneuropathy
  - 6.7.1. Global Immunoglobulin market for Chronic Inflammatory Demyelinating Polyneuropathy, 2017 - 2024 (USD Billion)
- 6.8. Idiopathic Thrombocytopenic Purpura
  - 6.8.1. Global Immunoglobulin market for Idiopathic Thrombocytopenic Purpura, 2017 - 2024 (USD Billion)
- 6.9. Specific Antibody Deficiency
  - 6.9.1. Global Immunoglobulin market for Specific Antibody Deficiency, 2017 - 2024 (USD Billion)
- 6.10. Inflammatory Myopathies
  - 6.10.1. Global Immunoglobulin market for Inflammatory Myopathies, 2017 - 2024 (USD Billion)
- 6.11. Others
  - 6.11.1. Global Immunoglobulin market for Others, 2017 - 2024 (USD Billion)
Chapter 7. Global Immunoglobulin Market - Product Type Analysis
- 7.1. Global Immunoglobulin market: Application overview
  - 7.1.1. Global Immunoglobulin market revenue share, by Product Type, 2017 and 2024
- 7.2. IgA
  - 7.2.1. Global Immunoglobulin market for IgA, 2017 - 2024 (USD Billion)
- 7.3. IgD
  - 7.3.1. Global Immunoglobulin market for IgD, 2017 - 2024 (USD Billion)
- 7.4. IgG
  - 7.4.1. Global Immunoglobulin market for IgG, 2017 - 2024 (USD Billion)
- 7.5. IgE
  - 7.5.1. Global Immunoglobulin market for IgE, 2017 - 2024 (USD Billion)
- 7.6. IgM
  - 7.6.1. Global Immunoglobulin market for IgM, 2017 - 2024 (USD Billion)
Chapter 8. Global Immunoglobulin Market - Regional Analysis
- 8.1. Global Immunoglobulin market: Regional overview
  - 8.1.1. Global Immunoglobulin market revenue share, by region, 2017 and 2024
- 8.2. North America
  - 8.2.1. North America Immunoglobulin market revenue, by Mode of Delivery, 2017 - 2024(USD Billion)
  - 8.2.2. North America Immunoglobulin market revenue, by Application, 2017 - 2024 (USD Billion)
  - 8.2.3. North America Immunoglobulin market revenue, by Product Type, 2017 - 2024 (USD Billion)
  - 8.2.4. The U.S.
    - 8.2.4.1. The U.S. Immunoglobulin market revenue, by Mode of Delivery, 2017 - 2024(USD Billion)
    - 8.2.4.2. The U.S. Immunoglobulin market revenue, by Application, 2017 - 2024 (USD Billion)
    - 8.2.4.3. The U.S. Immunoglobulin market revenue, by Product Type, 2017 - 2024 (USD Billion)
  - 8.2.5. Rest of North America
    - 8.2.5.1. Rest of North America Immunoglobulin market revenue, by Mode of Delivery, 2017 - 2024(USD Billion)
    - 8.2.5.2. Rest of North America Immunoglobulin market revenue, by Application, 2017 - 2024 (USD Billion)
    - 8.2.5.3. Rest of North America Immunoglobulin market revenue, by Product Type, 2017 - 2024 (USD Billion)
- 8.3. Europe
  - 8.3.1. Europe Immunoglobulin market revenue, by Mode of Delivery, 2017 - 2024(USD Billion)
  - 8.3.2. Europe Immunoglobulin market revenue, by Application, 2017 - 2024 (USD Billion)
  - 8.3.3. Europe Immunoglobulin market revenue, by Product Type, 2017 - 2024 (USD Billion)
  - 8.3.4. Germany
    - 8.3.4.1. Germany Immunoglobulin market revenue, by Mode of Delivery, 2017 - 2024(USD Billion)
    - 8.3.4.2. Germany Immunoglobulin market revenue, by Application, 2017 - 2024 (USD Billion)
    - 8.3.4.3. Germany Immunoglobulin market revenue, by Product Type, 2017 - 2024 (USD Billion)
  - 8.3.5. UK
    - 8.3.5.1. UK Immunoglobulin market revenue, by Mode of Delivery, 2017 - 2024(USD Billion)
    - 8.3.5.2. UK Immunoglobulin market revenue, by Application, 2017 - 2024 (USD Billion)
    - 8.3.5.3. UK Immunoglobulin market revenue, by Product Type, 2017 - 2024 (USD Billion)
  - 8.3.6. France
    - 8.3.6.1. France Immunoglobulin market revenue, by Mode of Delivery, 2017 - 2024(USD Billion)
    - 8.3.6.2. France Immunoglobulin market revenue, by Application, 2017 - 2024 (USD Billion)
    - 8.3.6.3. France Immunoglobulin market revenue, by Product Type, 2017 - 2024 (USD Billion)
  - 8.3.7. Rest of Europe
    - 8.3.7.1. Rest of Europe Immunoglobulin market revenue, by Mode of Delivery, 2017 - 2024(USD Billion)
    - 8.3.7.2. Rest of Europe Immunoglobulin market revenue, by Application, 2017 - 2024 (USD Billion)
    - 8.3.7.3. Rest of Europe Immunoglobulin market revenue, by Product Type, 2017 - 2024 (USD Billion)
- 8.4. Asia Pacific
  - 8.4.1. Asia Pacific Immunoglobulin market revenue, by Mode of Delivery, 2017 - 2024(USD Billion)
  - 8.4.2. Asia Pacific Immunoglobulin market revenue, by Application, 2017 - 2024 (USD Billion)
  - 8.4.3. Asia Pacific Immunoglobulin market revenue, by Product Type, 2017 - 2024 (USD Billion)
  - 8.4.4. China
    - 8.4.4.1. China Immunoglobulin market revenue, by Mode of Delivery, 2017 - 2024(USD Billion)
    - 8.4.4.2. China Immunoglobulin market revenue, by Application, 2017 - 2024 (USD Billion)
    - 8.4.4.3. China Immunoglobulin market revenue, by Product Type, 2017 - 2024 (USD Billion)
  - 8.4.5. Japan
    - 8.4.5.1. Japan Immunoglobulin market revenue, by Mode of Delivery, 2017 - 2024(USD Billion)
    - 8.4.5.2. Japan Immunoglobulin market revenue, by Application, 2017 - 2024 (USD Billion)
    - 8.4.5.3. Japan Immunoglobulin market revenue, by Product Type, 2017 - 2024 (USD Billion)
  - 8.4.6. India
    - 8.4.6.1. India Immunoglobulin market revenue, by Mode of Delivery, 2017 - 2024(USD Billion)
    - 8.4.6.2. India Immunoglobulin market revenue, by Application, 2017 - 2024 (USD Billion)
    - 8.4.6.3. India Immunoglobulin market revenue, by Product Type, 2017 - 2024 (USD Billion)
  - 8.4.7. Rest of Asia Pacific
    - 8.4.7.1. Rest of Asia Pacific Immunoglobulin market revenue, by Mode of Delivery, 2017 - 2024(USD Billion)
    - 8.4.7.2. Rest of Asia Pacific Immunoglobulin market revenue, by Application, 2017 - 2024 (USD Billion)
    - 8.4.7.3. Rest of Asia Pacific Immunoglobulin market revenue, by Product Type, 2017 - 2024 (USD Billion)
- 8.5. Latin America
  - 8.5.1. Latin America Immunoglobulin market revenue, by Mode of Delivery, 2017 - 2024(USD Billion)
  - 8.5.2. Latin America Immunoglobulin market revenue, by Application, 2017 - 2024 (USD Billion)
  - 8.5.3. Latin America Immunoglobulin market revenue, by Product Type, 2017 - 2024 (USD Billion)
  - 8.5.4. Brazil
    - 8.5.4.1. Brazil Immunoglobulin market revenue, by Mode of Delivery, 2017 - 2024(USD Billion)
    - 8.5.4.2. Brazil Immunoglobulin market revenue, by Application, 2017 - 2024 (USD Billion)
    - 8.5.4.3. Brazil Immunoglobulin market revenue, by Product Type, 2017 - 2024 (USD Billion)
  - 8.5.5. Rest of Latin America
    - 8.5.5.1. Rest of Latin America Immunoglobulin market revenue, by Mode of Delivery, 2017 - 2024(USD Billion)
    - 8.5.5.2. Rest of Latin America Immunoglobulin market revenue, by Application, 2017 - 2024 (USD Billion)
    - 8.5.5.3. Rest of Latin America Immunoglobulin market revenue, by Product Type, 2017 - 2024 (USD Billion)
- 8.6. The Middle East and Africa
  - 8.6.1. The Middle East and Africa Immunoglobulin market revenue, by Mode of Delivery, 2017 - 2024(USD Billion)
  - 8.6.2. The Middle East and Africa Immunoglobulin market revenue, by Application, 2017 - 2024 (USD Billion)
  - 8.6.3. The Middle East and Africa Immunoglobulin market revenue, by Product Type, 2017 - 2024 (USD Billion)
Chapter 9. Company Profile
- 9.1. ADMA Biologics, Inc.
  - 9.1.1. Overview
  - 9.1.2. Financials
  - 9.1.3. Therapy portfolio
  - 9.1.4. Business strategy
  - 9.1.5. Recent developments
- 9.2. Shire plc
  - 9.2.1. Overview
  - 9.2.2. Financials
  - 9.2.3. Therapy portfolio
  - 9.2.4. Business strategy
  - 9.2.5. Recent developments
- 9.3. CSL Behring LLC
  - 9.3.1. Overview
  - 9.3.2. Financials
  - 9.3.3. Therapy portfolio
  - 9.3.4. Business strategy
  - 9.3.5. Recent developments
- 9.4. Alta Genetics
  - 9.4.1. Overview
  - 9.4.2. Financials
  - 9.4.3. Therapy portfolio
  - 9.4.4. Business strategy
  - 9.4.5. Recent developments
- 9.5. China Biologic Products, Inc.
  - 9.5.1. Overview
  - 9.5.2. Financials
  - 9.5.3. Therapy portfolio
  - 9.5.4. Business strategy
  - 9.5.5. Recent developments
- 9.6. Grifols S.A.
  - 9.6.1. Overview
  - 9.6.2. Financials
  - 9.6.3. Therapy portfolio
  - 9.6.4. Business strategy
  - 9.6.5. Recent developments
- 9.7. LFB Biomedicaments S.A.
  - 9.7.1. Overview
  - 9.7.2. Financials
  - 9.7.3. Therapy portfolio
  - 9.7.4. Business strategy
  - 9.7.5. Recent developments
- 9.8. Kedrion S.p.A.
  - 9.8.1. Overview
  - 9.8.2. Financials
  - 9.8.3. Therapy portfolio
  - 9.8.4. Business strategy
  - 9.8.5. Recent developments
- 9.9. Sanquin Plasma Products B.V.
  - 9.9.1. Overview
  - 9.9.2. Financials
  - 9.9.3. Therapy portfolio
  - 9.9.4. Business strategy
  - 9.9.5. Recent developments
- 9.10. Octapharma AG
  - 9.10.1. Overview
  - 9.10.2. Financials
  - 9.10.3. Therapy portfolio
  - 9.10.4. Business strategy
  - 9.10.5. Recent developments

Table Of Figures

List of Figures

1. Market research process
2. Market research methodology
3. Global Immunoglobulin market revenue, 2017–2024(USD Billion)
4. Porter’s five forces analysis
5. Immunoglobulin Market attractiveness analysis, by Mode of Delivery
6. Immunoglobulin Market attractiveness analysis, by Application
7. Immunoglobulin Market attractiveness analysis, by Product Type
8. Immunoglobulin: Market attractiveness analysis, by Region
9. Company market share analysis, 2017
10. Global Immunoglobulin market revenue share by Mode of Delivery, 2017 and 2024
11. Global Immunoglobulin market for Subcutaneous, 2017 – 2024(USD Billion)
12. Global Immunoglobulin market for Intravenous, 2017 – 2024 (USD Billion)
13. Global Immunoglobulin market revenue share by Application, 2017 and 2024
14. Global Immunoglobulin market for Hypogammaglobulinemia, 2017 – 2024 (USD Billion)
15. Global Immunoglobulin market for Immunodeficiency Disease, 2017 – 2024 (USD Billion)
16. Global Immunoglobulin market for Multifocal Motor Neuropathy, 2017 – 2024 (USD Billion)
17. Global Immunoglobulin market for Guillain-Barre Syndrome, 2017 – 2024 (USD Billion)
18. Global Immunoglobulin market for Myasthenia Gravis, 2017 – 2024 (USD Billion)
19. Global Immunoglobulin market for Chronic Inflammatory Demyelinating Polyneuropathy, 2017 – 2024 (USD Billion)
20. Global Immunoglobulin market for Idiopathic Thrombocytopenic Purpura, 2017 – 2024 (USD Billion)
21. Global Immunoglobulin market for Specific Antibody Deficiency, 2017 – 2024 (USD Billion)
22. Global Immunoglobulin market for Inflammatory Myopathies, 2017 – 2024 (USD Billion)
23. Global Immunoglobulin market for Others, 2017 – 2024 (USD Billion)
24. North America Immunoglobulin market, 2017 - 2024 (USD Billion)
25. Europe Immunoglobulin market, 2017 - 2024 (USD Billion)
26. Asia Pacific Immunoglobulin market, 2017 - 2024 (USD Billion)
27. Latin America Immunoglobulin market, 2017 - 2024 (USD Billion)
28. The Middle East and Africa Immunoglobulin market, 2017 - 2024 (USD Billion)

Table Of Tables

List of Tables

1. Immunoglobulin market: Market Snapshot
2. Drivers of global Immunoglobulin market: Impact analysis
3. Restraints of global Immunoglobulin market: Impact analysis
4. Opportunities of global Immunoglobulin market: Impact analysis
5. North America Immunoglobulin market revenue, by Mode of Delivery, 2017 – 2024 (USD Billion)
6. North America Immunoglobulin market revenue, by Subcutaneous, 2017 – 2024 (USD Billion)
7. North America Immunoglobulin market revenue, by Intravenous, 2017 – 2024 (USD Billion)
8. North America Immunoglobulin market revenue, by Application, 2017 – 2024 (USD Billion)
9. North America Immunoglobulin market revenue, by Product Type, 2017 – 2024 (USD Billion)
10. The U.S. Immunoglobulin market revenue, by Mode of Delivery, 2017 – 2024 (USD Billion)
11. The U.S. Immunoglobulin market revenue, by Subcutaneous, 2017 – 2024 (USD Billion)
12. The U.S. Immunoglobulin market revenue, by Intravenous, 2017 – 2024 (USD Billion)
13. The U.S. Immunoglobulin market revenue, by Application, 2017 – 2024 (USD Billion)
14. The U.S. Immunoglobulin market revenue, by Product Type, 2017 – 2024 (USD Billion)
15. Rest of North America Immunoglobulin market revenue, by Mode of Delivery, 2017 – 2024 (USD Billion)
16. Rest of North America Immunoglobulin market revenue, by Subcutaneous, 2017 – 2024 (USD Billion)
17. Rest of North America Immunoglobulin market revenue, by Intravenous, 2017 – 2024 (USD Billion)
18. Rest of North America Immunoglobulin market revenue, by Application, 2017 – 2024 (USD Billion)
19. Rest of North America Immunoglobulin market revenue, by Product Type, 2017 – 2024 (USD Billion)
20. Europe Immunoglobulin market revenue, by Mode of Delivery, 2017 – 2024(USD Billion)
21. Europe Immunoglobulin market revenue, by Subcutaneous, 2017 – 2024 (USD Billion)
22. Europe Immunoglobulin market revenue, by Intravenous, 2017 – 2024 (USD Billion)
23. Europe Immunoglobulin market revenue, by Application, 2017 – 2024 (USD Billion)
24. Europe Immunoglobulin market revenue, by Product Type, 2017 – 2024 (USD Billion)
25. Germany Immunoglobulin market revenue, by Mode of Delivery, 2017 – 2024 (USD Billion)
26. Germany Immunoglobulin market revenue, by Subcutaneous, 2017 – 2024 (USD Billion)
27. Germany Immunoglobulin market revenue, by Intravenous, 2017 – 2024 (USD Billion)
28. Germany Immunoglobulin market revenue, by Application, 2017 – 2024 (USD Billion)
29. Germany Immunoglobulin market revenue, by Product Type, 2017 – 2024 (USD Billion)
30. UK Immunoglobulin market revenue, by Mode of Delivery, 2017 – 2024 (USD Billion)
31. UK Immunoglobulin market revenue, by Subcutaneous, 2017 – 2024 (USD Billion)
32. UK Immunoglobulin market revenue, by Intravenous, 2017 – 2024 (USD Billion)
33. UK Immunoglobulin market revenue, by Application, 2017 – 2024 (USD Billion)
34. UK Immunoglobulin market revenue, by Product Type, 2017 – 2024 (USD Billion)
35. France Immunoglobulin market revenue, by Mode of Delivery, 2017 – 2024 (USD Billion)
36. France Immunoglobulin market revenue, by Subcutaneous, 2017 – 2024 (USD Billion)
37. France Immunoglobulin market revenue, by Intravenous, 2017 – 2024 (USD Billion)
38. France Immunoglobulin market revenue, by Application, 2017 – 2024 (USD Billion)
39. France Immunoglobulin market revenue, by Product Type, 2017 – 2024 (USD Billion)
40. Rest of Europe Immunoglobulin market revenue, by Mode of Delivery, 2017 – 2024 (USD Billion)
41. Rest of Europe Immunoglobulin market revenue, by Subcutaneous, 2017 – 2024 (USD Billion)
42. Rest of Europe Immunoglobulin market revenue, by Intravenous, 2017 – 2024 (USD Billion)
43. Rest of Europe Immunoglobulin market revenue, by Application, 2017 – 2024 (USD Billion)
44. Rest of Europe Immunoglobulin market revenue, by Product Type, 2017 – 2024 (USD Billion)
45. Asia Pacific Immunoglobulin market revenue, by Mode of Delivery, 2017 – 2024 (USD Billion)
46. Asia Pacific Immunoglobulin market revenue, by Subcutaneous, 2017 – 2024 (USD Billion)
47. Asia Pacific Immunoglobulin market revenue, by Intravenous, 2017 – 2024 (USD Billion)
48. Asia Pacific Immunoglobulin market revenue, by Application, 2017 – 2024 (USD Billion)
49. Asia Pacific Immunoglobulin market revenue, by Product Type, 2017 – 2024 (USD Billion)
50. China Immunoglobulin market revenue, by Mode of Delivery, 2017 – 2024 (USD Billion)
51. China Immunoglobulin market revenue, by Subcutaneous, 2017 – 2024 (USD Billion)
52. China Immunoglobulin market revenue, by Intravenous, 2017 – 2024 (USD Billion)
53. China Immunoglobulin market revenue, by Application, 2017 – 2024 (USD Billion)
54. China Immunoglobulin market revenue, by Product Type, 2017 – 2024 (USD Billion)
55. Japan Immunoglobulin market revenue, by Mode of Delivery, 2017 – 2024 (USD Billion)
56. Japan Immunoglobulin market revenue, by Subcutaneous, 2017 – 2024 (USD Billion)
57. Japan Immunoglobulin market revenue, by Intravenous, 2017 – 2024 (USD Billion)
58. Japan Immunoglobulin market revenue, by Application, 2017 – 2024 (USD Billion)
59. Japan Immunoglobulin market revenue, by Product Type, 2017 – 2024 (USD Billion)
60. India Immunoglobulin market revenue, by Mode of Delivery, 2017 – 2024 (USD Billion)
61. India Immunoglobulin market revenue, by Subcutaneous, 2017 – 2024 (USD Billion)
62. India Immunoglobulin market revenue, by Intravenous, 2017 – 2024 (USD Billion)
63. India Immunoglobulin market revenue, by Application, 2017 – 2024 (USD Billion)
64. India Immunoglobulin market revenue, by Product Type, 2017 – 2024 (USD Billion)
65. Rest of Asia Pacific Immunoglobulin market revenue, by Mode of Delivery, 2017 – 2024 (USD Billion)
66. Rest of Asia Pacific Immunoglobulin market revenue, by Subcutaneous, 2017 – 2024 (USD Billion)
67. Rest of Asia Pacific Immunoglobulin market revenue, by Intravenous, 2017 – 2024 (USD Billion)
68. Rest of Asia Pacific Immunoglobulin market revenue, by Application, 2017 – 2024 (USD Billion)
69. Rest of Asia Pacific Immunoglobulin market revenue, by Product Type, 2017 – 2024 (USD Billion)
70. Latin America Immunoglobulin market revenue, by Mode of Delivery, 2017 – 2024 (USD Billion)
71. Latin America Immunoglobulin market revenue, by Subcutaneous, 2017 – 2024 (USD Billion)
72. Latin America Immunoglobulin market revenue, by Intravenous, 2017 – 2024 (USD Billion)
73. Latin America Immunoglobulin market revenue, by Application, 2017 – 2024 (USD Billion)
74. Latin America Immunoglobulin market revenue, by Product Type, 2017 – 2024 (USD Billion)
75. Brazil Immunoglobulin market revenue, by Mode of Delivery, 2017 – 2024 (USD Billion)
76. Brazil Immunoglobulin market revenue, by Subcutaneous, 2017 – 2024 (USD Billion)
77. Brazil Immunoglobulin market revenue, by Intravenous, 2017 – 2024 (USD Billion)
78. Brazil Immunoglobulin market revenue, by Application, 2017 – 2024 (USD Billion)
79. Brazil Immunoglobulin market revenue, by Product Type, 2017 – 2024 (USD Billion)
80. Rest of Latin America Immunoglobulin market revenue, by Mode of Delivery, 2017 – 2024 (USD Billion)
81. Rest of Latin America Immunoglobulin market revenue, by Subcutaneous, 2017 – 2024 (USD Billion)
82. Rest of Latin America Immunoglobulin market revenue, by Intravenous, 2017 – 2024 (USD Billion)
83. Rest of Latin America Immunoglobulin market revenue, by Application, 2017 – 2024 (USD Billion)
84. Rest of Latin America Immunoglobulin market revenue, by Product Type, 2017 – 2024 (USD Billion)
85. The Middle East and Africa Immunoglobulin market revenue, by Mode of Delivery, 2017 – 2024 (USD Billion)
86. The Middle East and Africa Immunoglobulin market revenue, by Subcutaneous, 2017 – 2024 (USD Billion)
87. The Middle East and Africa Immunoglobulin market revenue, by Intravenous, 2017 – 2024 (USD Billion)
88. The Middle East and Africa Immunoglobulin market revenue, by Application, 2017 – 2024 (USD Billion)
89. The Middle East and Africa Immunoglobulin market revenue, by Product Type, 2017 – 2024 (USD Billion)

Methodology

Free Analysis

Immunoglobulins are glycoprotein molecules that are produced by white blood cells (plasma cells). Immunoglobulins, also referred to as antibodies, operate as a perilous portion of the immune response by precisely recognizing and attaching themselves to specific antigens, such as viruses or bacteria, and assisting in their annihilation. This antibody response is extremely complex and exceptionally specific. The amino acid configuration of antibodies differs, thereby permitting them to interact with numerous diverse antigens. The applications of immunoglobulin include disease diagnosis, disease therapy, and prenatal therapy. The numerous antibodies manufactured by plasma cells are categorized by isotype, where every single type varies in role and antigen responses chiefly due to assembly variability.

The growing incidences of autoimmune diseases, such as multiple sclerosis, primary humoral immunodeficiency, immune thrombocytopenia purpura (ITP), Kawasaki syndrome, and autoimmune hemolytic anemia, increasing geriatric population worldwide, steep rise in the cases of neurological disorders, and rising hemophilic patient numbers are likely to drive the global immunoglobulin market in the upcoming years. Technological advancements in purification and production methods along with the efforts taken by government and non-government organizations to create awareness regarding autoimmune diseases are anticipated to further fuel the immunoglobulin market over the estimated timeframe. Nonetheless, strict government guidelines related to immunoglobulin products and several side effects of immunoglobulin use might restrict the global immunoglobulin market on a global scale.

Global Immunoglobulin Market

By mode of delivery, the immunoglobulin market is segmented into subcutaneous and intravenous. Subcutaneous is further segmented into 16.5% concentration, 20% concentration, and others. Intravenous is further segmented into 5% concentration, 10% concentration, and others. The application segment includes Hypogammaglobulinemia, Immunodeficiency Disease, Multifocal Motor Neuropathy, Guillain-Barre Syndrome, Myasthenia Gravis, Chronic Inflammatory Demyelinating Polyneuropathy, Idiopathic Thrombocytopenic Purpura, Specific Antibody Deficiency, Inflammatory Myopathies, and others. By product type, this market includes IgA, IgD, IgG, IgE, and IgM.

By region, the North American immunoglobulin market is likely to lead over the forecast time period. This can be attributed to the presence of a high number of major players operating in the immunoglobulin market, the existence of big plasma manufacturing units, high acceptance of modern technologies in immunoglobulin, and the region’s well-established healthcare sector. Europe is anticipated to be the second largest immunoglobulin market in the future, owing to the growing geriatric population and increasing number of hemophilic patients. The maximum percentage of people aged 60 or above are in Europe. The Asia Pacific market is projected to propagate at a speedy rate over the forecast period, owing to the growing per capita healthcare expenditure, rapid advancement of healthcare infrastructure, and increased focus on research and development. The Latin American immunoglobulin market is likely to grow significantly over the estimated time period.

Some key players of the global immunoglobulin market include ADMA Biologics, Inc., Shire plc, CSL Behring LLC, China Biologic Products, Inc., Grifols S.A., LFB Biomedicaments S.A., Kedrion S.p.A., Sanquin Plasma Products B.V., and Octapharma AG, among others.?